©2022 Stanford Medicine
Clinical Trials Contact
About this Clinical Trial
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Your Message Will Go To
Rene Bonilla
650-498-7703
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Rene Bonilla
650-498-7703